| Trial ID: | L0960 |
| Source ID: | NCT01068444
|
| Associated Drug: |
Pioglitazone
|
| Title: |
A Double-Blind, Randomized, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Hepatitis
|
| Interventions: |
Drug: Pioglitazone;Drug: placebo
|
| Outcome Measures: |
Comparison between Pioglitazone and placebo groups in terms of steatosis and liver function tests;Evaluation of clinical safety of PioglitazoneComparison between Pioglitazone and placebo groups in terms of liver necroinflammation and fibrosis.
|
| Sponsor/Collaborators: |
Kaohsiung Medical University Chung-Ho Memorial Hospital
|
| Gender: |
All
|
| Age: |
18 Years70 Years
|
| Phases: |
Phase 2
|
| Enrollment: |
90
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
|
| Start Date: |
11/02/2010
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT01068444
|
